Biological activity of recently discovered halogenated marine natural products
GW Gribble - Marine drugs, 2015 - mdpi.com
This review presents the biological activity—antibacterial, antifungal, anti-parasitic, antiviral,
antitumor, antiinflammatory, antioxidant, and enzymatic activity—of halogenated marine …
antitumor, antiinflammatory, antioxidant, and enzymatic activity—of halogenated marine …
Natural products to drugs: natural product derived compounds in clinical trials
MS Butler - Natural product reports, 2005 - pubs.rsc.org
Covering: 31st December 2004Natural product and natural product-derived compounds that
are being evaluated in clinical trials or in registration (current 31 December 2004) have …
are being evaluated in clinical trials or in registration (current 31 December 2004) have …
Therapeutic applications of conotoxins that target the neuronal nicotinic acetylcholine receptor
BG Livett, DW Sandall, D Keays, J Down, KR Gayler… - Toxicon, 2006 - Elsevier
Pain therapeutics discovered by molecular mining of the expressed genome of Australian
predatory cone snails are providing lead compounds for the treatment of neurological …
predatory cone snails are providing lead compounds for the treatment of neurological …
Ligand-based peptide design and combinatorial peptide libraries to target G protein-coupled receptors
C W. Gruber, M Muttenthaler… - Current pharmaceutical …, 2010 - benthamdirect.com
G protein-coupled receptors (GPCRs) are considered to represent the most promising drug
targets; it has been repeatedly said that a large fraction of the currently marketed drugs elicit …
targets; it has been repeatedly said that a large fraction of the currently marketed drugs elicit …
Conotoxins as research tools and drug leads
CJ Armishaw, PF Alewood - Current Protein and Peptide …, 2005 - ingentaconnect.com
The complex mixture of biologically active peptides that constitute the venom of Conus
species provides a rich source of ion channel neurotoxins. These peptides, commonly …
species provides a rich source of ion channel neurotoxins. These peptides, commonly …
Synthesis and biological evaluation of nonpeptide mimetics of ω-conotoxin GVIA
A benzothiazole-derived compound (4a) designed to mimic the Cα–Cβ bond vectors and
terminal functionalities of Lys2, Tyr13 and Arg17 in ω-conotoxin GVIA was synthesised …
terminal functionalities of Lys2, Tyr13 and Arg17 in ω-conotoxin GVIA was synthesised …
Strategies for the development of conotoxins as new therapeutic leads
Peptide toxins typically bind to their target ion channels or receptors with high potency and
selectivity, making them attractive leads for therapeutic development. In some cases the …
selectivity, making them attractive leads for therapeutic development. In some cases the …
Methods for the synthesis of two or more dicarba bridges in organic compounds
US7538190B2 - Methods for the synthesis of two or more dicarba bridges in organic
compounds - Google Patents US7538190B2 - Methods for the synthesis of two or more dicarba …
compounds - Google Patents US7538190B2 - Methods for the synthesis of two or more dicarba …
Conotoxin analogues and methods for synthesis of intramolecular dicarba bridge-containing peptides
A Robinson, J Elaridi - US Patent 7,745,573, 2010 - Google Patents
US7745573B2 - Conotoxin analogues and methods for synthesis of intramolecular dicarba
bridge-containing peptides - Google Patents US7745573B2 - Conotoxin analogues and …
bridge-containing peptides - Google Patents US7745573B2 - Conotoxin analogues and …
Synthetic α-conotoxin mutants as probes for studying nicotinic acetylcholine receptors and in the development of novel drug leads
CJ Armishaw - Toxins, 2010 - mdpi.com
α-Conotoxins are peptide neurotoxins isolated from venomous marine cone snails that are
potent and selective antagonists for different subtypes of nicotinic acetylcholine receptors …
potent and selective antagonists for different subtypes of nicotinic acetylcholine receptors …